As for the signaling pathways involving FAT4 in cancer, a recent study has reported FAT4 silencing to enhance EMT and invasiveness of ovarian cancer by regulating YAP and β-catenin activity [29]. The gene discussed is FAT4; the disease is ovarian carcinoma.